Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Immunosuppression"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1933
Tytuł:
Efficacy and safety of immunosuppressive therapy combined with eltrombopag for severe aplastic anemia: a systematic review and meta-analysis.
Autorzy:
Zhang Y; Department of Hematology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Li J; Department of Oncology and Hematology, Liuyang Hospital of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, 410300, Hunan, China.
Li X; Department of Nephrology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Geng Q; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Xie Y; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Zhang G; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China.
Wei M; Department of Hematology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China. .
Ma Y; Department of Hematology, Heji Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, Shanxi, China. .
Pokaż więcej
Źródło:
Systematic reviews [Syst Rev] 2024 Apr 04; Vol. 13 (1), pp. 101. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
Anemia, Aplastic*/drug therapy
Anemia, Aplastic*/epidemiology
Hydrazines*
Pyrazoles*
Humans ; Immunosuppression Therapy ; Benzoates/therapeutic use ; Pathologic Complete Response ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Role of topical and systemic immunosuppression in aqueous-deficient dry eye disease.
Autorzy:
Kate A; Shantilal Shanghvi Cornea Institue, LV Prasad Eye Institute, Vijayawada, Andhra Pradesh, India.
Shanbhag SS; Shantilal Shanghvi Cornea Institue, LV Prasad Eye Institute, Hyderabad, Telengana, India.
Donthineni PR; Shantilal Shanghvi Cornea Institue, LV Prasad Eye Institute, Hyderabad, Telengana, India.
Amescua G; Department of Ophthalmology, Duke Eye Center, Duke University School of Medicine, Durham 27705, NC, USA.
Quinones VLP; Foster Center for Ocular Immunology, Department of Ophthalmology, Duke Eye Center, Duke University School of Medicine, Durham, North Carolina, USA.
Basu S; Shantilal Shanghvi Cornea Institue, LV Prasad Eye Institute; Center for Ocular Regeneration (CORE), L. V. Prasad Eye Institute; Brien Holden Eye Research Centre, L. V. Prasad Eye Institute, Hyderabad, Telangana, India.
Pokaż więcej
Źródło:
Indian journal of ophthalmology [Indian J Ophthalmol] 2023 Apr; Vol. 71 (4), pp. 1176-1189.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Dry Eye Syndromes*/drug therapy
Immunosuppressive Agents*/therapeutic use
Humans ; Azathioprine/therapeutic use ; Immunosuppression Therapy ; Inflammation ; Methotrexate/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A viewpoint describing the American Society of Transplantation rationale to conduct a comprehensive patient survey assessing unmet immunosuppressive therapy needs.
Autorzy:
Taber DJ; Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Gordon EJ; Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Jesse MT; Henry Ford Transplant Institute, Internal Medicine, Henry Ford Health, Detroit, Michigan, USA.
Myaskovsky L; Center for Healthcare Equity in Kidney Disease and Department of Internal Medicine, University of New Mexico, Health Sciences Center, Albuquerque, New Mexico, USA.
Peipert JD; Department of Medical Social, Sciences & Northwestern University Transplant Outcomes Research Collaboration, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Jaure A; Sydney School of Public Health, The University of Sydney, Camperdown, Sydney, Australia.
George R; Emory University and Children's Healthcare of Atlanta, Atlanta, Georgia.
Fitzsimmons W; Colleges of Pharmacy and Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Pokaż więcej
Corporate Authors:
American Society of Transplantation Board of Directors
Źródło:
Clinical transplantation [Clin Transplant] 2023 Mar; Vol. 37 (3), pp. e14876. Date of Electronic Publication: 2022 Dec 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunosuppressive Agents*/therapeutic use
Organ Transplantation*
Humans ; United States ; Quality of Life ; Immunosuppression Therapy ; Surveys and Questionnaires ; Graft Rejection/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading?
Autorzy:
Daoud A; Nephrology Unit, Internal Medicine Department, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.
Alqassieh A; Department of Surgery, Medical University of South Carolina, Charleston, SC, USA.
Alkhader D; Department of Surgery, Medical University of South Carolina, Charleston, SC, USA.
Posadas Salas MA; Department of Surgery, Medical University of South Carolina, Charleston, SC, USA.; Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC, USA.
Rao V; Department of Surgery, Medical University of South Carolina, Charleston, SC, USA.; Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC, USA.
Fülöp T; Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC, USA.; Medicine Service, Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
Soliman KM; Department of Surgery, Medical University of South Carolina, Charleston, SC, USA.; Department of Medicine, Division of Nephrology, Medical University of South Carolina, Charleston, SC, USA.
Pokaż więcej
Źródło:
Renal failure [Ren Fail] 2021 Dec; Vol. 43 (1), pp. 273-280.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunosuppression Therapy*
Kidney Transplantation*
COVID-19/*complications
Immunosuppressive Agents/*therapeutic use
Renal Insufficiency/*complications
Renal Insufficiency/*surgery
Algorithms ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Malignancy risk of non-biologic immunosuppressive therapies: A review of the literature with evidence-based treatment recommendations.
Autorzy:
Scott S; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Shireen GR; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Rachel F; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Kirsner RS; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Maderal AD; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
Pokaż więcej
Źródło:
Experimental dermatology [Exp Dermatol] 2022 Nov; Vol. 31 (11), pp. 1656-1664. Date of Electronic Publication: 2022 Jul 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Immunosuppressive Agents*
Neoplasms*
Humans ; Retrospective Studies ; Risk ; Immunosuppression Therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.
Autorzy:
Tunbridge M; Central and Northern Adelaide Renal and Transplantation Service (CNARTS), The Royal Adelaide Hospital, Adelaide, South Australia, Australia. .
Perkins GB; School of Biological Sciences, The University of Adelaide, Adelaide, South Australia, Australia.; SA Pathology, Adelaide, South Australia, Australia.
Singer J; Department of Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Sydney, Australia.; Kidney Node, Charles Perkins Centre, University of Sydney, Sydney, Australia.
Salehi T; Central and Northern Adelaide Renal and Transplantation Service (CNARTS), The Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Ying T; Department of Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Sydney, Australia.; Kidney Node, Charles Perkins Centre, University of Sydney, Sydney, Australia.
Grubor-Bauk B; Discipline of Medicine, Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.; Viral Immunology Group, Basil Hetzel Institute for Translational Research, Adelaide, South Australia, Australia.
Barry S; Discipline of Medicine, Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.; Molecular Immunology, Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia.; Department of Paediatric Medicine, Women's and Children's Hospital, North Adelaide, South Australia, Australia.
Sim B; Central and Northern Adelaide Renal and Transplantation Service (CNARTS), The Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Hissaria P; Department of Immunology, The Royal Adelaide Hospital, Adelaide, South Australia, Australia.
Chadban SJ; Department of Renal Medicine, Kidney Centre, Royal Prince Alfred Hospital, Sydney, Australia.; Kidney Node, Charles Perkins Centre, University of Sydney, Sydney, Australia.
Coates PT; Central and Northern Adelaide Renal and Transplantation Service (CNARTS), The Royal Adelaide Hospital, Adelaide, South Australia, Australia.; Discipline of Medicine, Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
Pokaż więcej
Źródło:
Trials [Trials] 2022 Sep 15; Vol. 23 (1), pp. 780. Date of Electronic Publication: 2022 Sep 15.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
COVID-19*/prevention & control
COVID-19 Vaccines*/immunology
Immunosuppressive Agents*/adverse effects
Kidney Transplantation*/adverse effects
Humans ; Immunoglobulin G ; Immunosuppression Therapy ; Inulin ; Multicenter Studies as Topic ; Prednisolone ; Randomized Controlled Trials as Topic ; SARS-CoV-2 ; Sirolimus/adverse effects ; TOR Serine-Threonine Kinases ; Tacrolimus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression.
Autorzy:
Lionaki S; Department of Nephrology &Transplantation Unit, Laiko Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Makropoulos I; Department of Nephrology &Transplantation Unit, Laiko Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Panagiotellis K; Department of Nephrology &Transplantation Unit, Laiko Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Vlachopanos G; Department of Nephrology &Transplantation Unit, Laiko Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Gavalas I; Department of Nephrology &Transplantation Unit, Laiko Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Marinaki S; Department of Nephrology &Transplantation Unit, Laiko Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Liapis G; Department of Pathology, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Michelakis I; Department of Nephrology &Transplantation Unit, Laiko Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Bokos I; Transplantation Unit, Laiko Hospital, Athens, Greece.
Boletis I; Department of Nephrology &Transplantation Unit, Laiko Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Aug 17; Vol. 16 (8), pp. e0253337. Date of Electronic Publication: 2021 Aug 17 (Print Publication: 2021).
Typ publikacji:
Journal Article
MeSH Terms:
Immunosuppression Therapy*/methods
Kidney Transplantation*/methods
Glomerulonephritis/*therapy
Glomerulonephritis, IGA/*therapy
Immunosuppressive Agents/*therapeutic use
Kidney Failure, Chronic/*therapy
Adult ; Cyclosporine/therapeutic use ; Female ; Glomerulonephritis/immunology ; Glomerulonephritis, IGA/immunology ; Glomerulonephritis, Membranous/immunology ; Glomerulonephritis, Membranous/therapy ; Glomerulosclerosis, Focal Segmental/immunology ; Glomerulosclerosis, Focal Segmental/therapy ; Graft Survival/drug effects ; Humans ; Kidney Failure, Chronic/immunology ; Male ; Middle Aged ; Retrospective Studies ; Tacrolimus/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Assessment of Immunological Potential of Glial Restricted Progenitor Graft In Vivo-Is Immunosuppression Mandatory?
Autorzy:
Kozlowska U; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Klimczak A; Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland.; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Bednarowicz KA; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Zalewski T; NanoBioMedical Centre, Adam Mickiewicz University, 61-614 Poznan, Poland.
Rozwadowska N; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Chojnacka K; Institute of Bioorganic Chemistry, Polish Academy of Sciences, 61-704 Poznan, Poland.
Jurga S; NanoBioMedical Centre, Adam Mickiewicz University, 61-614 Poznan, Poland.
Barnea ER; The Society for the Investigation of Early Pregnancy (SIEP), Cherry Hill, NJ 08003, USA.; BioIncept LLC, Cherry Hill, NJ 08003, USA.
Kurpisz MK; Institute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Pokaż więcej
Źródło:
Cells [Cells] 2021 Jul 16; Vol. 10 (7). Date of Electronic Publication: 2021 Jul 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunosuppression Therapy*/methods
Stem Cells*/immunology
Central Nervous System/*drug effects
Immunosuppressive Agents/*therapeutic use
Neurodegenerative Diseases/*drug therapy
Animals ; Central Nervous System/immunology ; Disease Models, Animal ; Immune Tolerance/drug effects ; Mice ; Neurodegenerative Diseases/immunology ; Stem Cell Transplantation/methods
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Variation in immunosuppression practices among pediatric liver transplant centers-Society of Pediatric Liver Transplantation survey results.
Autorzy:
Slowik V; Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Children's Mercy Kansas City, University of Missouri - Kansas City School of Medicine, Kansas City, MO, USA.
Lerret SM; Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, WI, USA.
Lobritto SJ; Center for Liver Diseases and Transplantation, Department of Pediatrics and Medicine, Columbia University Irving Medical Center, New York, NY, USA.
Voulgarelis S; Division of Anesthesiology, Children's Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, WI, USA.
Vitola BE; Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Wisconsin and Medical College of Wisconsin, Milwaukee, WI, USA.
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2021 Mar; Vol. 25 (2), pp. e13873. Date of Electronic Publication: 2020 Oct 07.
Typ publikacji:
Journal Article
MeSH Terms:
Liver Transplantation*
Graft Rejection/*prevention & control
Healthcare Disparities/*statistics & numerical data
Immunosuppression Therapy/*methods
Immunosuppressive Agents/*therapeutic use
Practice Patterns, Physicians'/*statistics & numerical data
Adolescent ; Child ; Child, Preschool ; Cross-Sectional Studies ; Drug Therapy, Combination ; Graft Rejection/therapy ; Health Care Surveys ; Humans ; Immunosuppression Therapy/standards ; Immunosuppression Therapy/statistics & numerical data ; Induction Chemotherapy/methods ; Induction Chemotherapy/standards ; Induction Chemotherapy/statistics & numerical data ; Infant ; Infant, Newborn ; Maintenance Chemotherapy/methods ; Maintenance Chemotherapy/standards ; Maintenance Chemotherapy/statistics & numerical data ; Practice Patterns, Physicians'/standards ; Quality Improvement ; Societies, Medical ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
COVID-19 in kidney transplant recipients: A multicenter experience in Istanbul.
Autorzy:
Demir E; Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Uyar M; Division of Nephrology, Department of Internal Medicine, Gaziosmanpasa Hospital, Yeniyuzyil University, Istanbul, Turkey.
Parmaksiz E; Division of Nephrology, Department of Internal Medicine, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey.
Sinangil A; Division of Nephrology, Department of Internal Medicine, Florence Nightingale Hospital, Demiroglu Bilim University, Istanbul, Turkey.
Yelken B; Division of Nephrology, Department of Internal Medicine, Koc School of Medicine, Koc University, Istanbul, Turkey.
Dirim AB; Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Merhametsiz O; Division of Nephrology, Department of Internal Medicine, Gaziosmanpasa Hospital, Yeniyuzyil University, Istanbul, Turkey.
Yadigar S; Division of Nephrology, Department of Internal Medicine, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey.
Atan Ucar Z; Division of Nephrology, Department of Internal Medicine, Florence Nightingale Hospital, Demiroglu Bilim University, Istanbul, Turkey.
Ucar AR; Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Demir ME; Division of Nephrology, Department of Internal Medicine, Gaziosmanpasa Hospital, Yeniyuzyil University, Istanbul, Turkey.
Mese M; Division of Nephrology, Department of Internal Medicine, Kartal Dr. Lutfi Kirdar Training and Research Hospital, Istanbul, Turkey.
Akin EB; Division of Nephrology, Department of Internal Medicine, Florence Nightingale Hospital, Demiroglu Bilim University, Istanbul, Turkey.; Unit of Renal Transplantation, Department of General Surgery, Florence Nightingale Hospital, Demiroglu Bilim University, Istanbul, Turkey.
Garayeva N; Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Safak S; Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Oto OA; Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Yazici H; Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Turkmen A; Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.; Division of Nephrology, Department of Internal Medicine, Koc School of Medicine, Koc University, Istanbul, Turkey.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2020 Oct; Vol. 22 (5), pp. e13371. Date of Electronic Publication: 2020 Jul 13.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
COVID-19/*therapy
Immunosuppression Therapy/*standards
Immunosuppressive Agents/*adverse effects
Kidney Transplantation/*adverse effects
SARS-CoV-2/*immunology
Adult ; Aged ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19/diagnosis ; COVID-19/immunology ; COVID-19 Nucleic Acid Testing ; Critical Care/methods ; Critical Care/standards ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Drug Therapy, Combination/methods ; Drug Therapy, Combination/standards ; Female ; Follow-Up Studies ; Graft Rejection/immunology ; Graft Rejection/prevention & control ; Humans ; Immunosuppression Therapy/adverse effects ; Immunosuppression Therapy/methods ; Immunosuppressive Agents/administration & dosage ; Intensive Care Units/standards ; Interleukin 1 Receptor Antagonist Protein/therapeutic use ; Male ; Middle Aged ; Patient Admission/standards ; Practice Guidelines as Topic ; Respiration, Artificial/standards ; Retrospective Studies ; SARS-CoV-2/genetics ; SARS-CoV-2/isolation & purification ; Severity of Illness Index ; Transplant Recipients ; Treatment Outcome ; Turkey
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long-term experience using CNI-free immunosuppression in selected paediatric heart transplant recipients.
Autorzy:
Rosenthal LM; Department for Congenital Heart Disease/Pediatric Cardiology, German Heart Institute, Berlin, Germany.; Department for Pediatric Cardiology, Charité Universitätsmedizin, Berlin, Germany.
Nordmeyer J; Department for Congenital Heart Disease/Pediatric Cardiology, German Heart Institute, Berlin, Germany.
Kramer P; Department for Congenital Heart Disease/Pediatric Cardiology, German Heart Institute, Berlin, Germany.
Danne F; Department for Congenital Heart Disease/Pediatric Cardiology, German Heart Institute, Berlin, Germany.
Pfitzer C; Department for Congenital Heart Disease/Pediatric Cardiology, German Heart Institute, Berlin, Germany.
Berger F; Department for Congenital Heart Disease/Pediatric Cardiology, German Heart Institute, Berlin, Germany.; Department for Pediatric Cardiology, Charité Universitätsmedizin, Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Berlin, Germany.
Schmitt KRL; Department for Congenital Heart Disease/Pediatric Cardiology, German Heart Institute, Berlin, Germany.; Department for Pediatric Cardiology, Charité Universitätsmedizin, Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Berlin, Germany.
Schubert S; Department for Congenital Heart Disease/Pediatric Cardiology, German Heart Institute, Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Berlin, Germany.; Center of Congenital Heart Disease, Heart and Diabetes Center North Rhine-Westfalia (HDZ-NRW), Ruhr-University of Bochum, Bad Oeynhausen, Germany.
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2021 Dec; Vol. 25 (8), pp. e14111. Date of Electronic Publication: 2021 Aug 18.
Typ publikacji:
Journal Article
MeSH Terms:
Heart Transplantation*
Graft Rejection/*diagnostic imaging
Graft Rejection/*immunology
Immunosuppression Therapy/*methods
Immunosuppressive Agents/*therapeutic use
Adolescent ; Calcineurin Inhibitors ; Child ; Child, Preschool ; Everolimus/therapeutic use ; Female ; Glomerular Filtration Rate ; Graft Survival ; Humans ; Lymphoproliferative Disorders/immunology ; Male ; Retrospective Studies ; Sirolimus/therapeutic use ; Tomography, Optical Coherence ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs.
Autorzy:
Parlakpinar H; Department of Medical Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey.
Gunata M; Department of Medical Pharmacology, Faculty of Medicine, Inonu University, Malatya, Turkey.
Pokaż więcej
Źródło:
Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2021 Dec; Vol. 43 (6), pp. 651-665. Date of Electronic Publication: 2021 Aug 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Graft Rejection/*prevention & control
Immunosuppression Therapy/*methods
Immunosuppressive Agents/*therapeutic use
Organ Transplantation/*adverse effects
Transplants/*drug effects
Abatacept/pharmacology ; Abatacept/therapeutic use ; Bortezomib/pharmacology ; Bortezomib/therapeutic use ; Clinical Trials as Topic/methods ; Cyclosporine/pharmacology ; Cyclosporine/therapeutic use ; Graft Rejection/immunology ; Humans ; Immunosuppressive Agents/pharmacology ; Organ Transplantation/trends ; Transplants/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Induction and maintenance immunosuppression in pediatric kidney transplantation-Advances and controversies.
Autorzy:
Balani SS; Pediatric Nephrology, University of Minnesota, Minneapolis, MN, USA.
Jensen CJ; Solid Organ Transplant, University of Minnesota, Minneapolis, MN, USA.
Kouri AM; Pediatric Nephrology, University of Minnesota, Minneapolis, MN, USA.
Kizilbash SJ; Pediatric Nephrology, University of Minnesota, Minneapolis, MN, USA.
Pokaż więcej
Źródło:
Pediatric transplantation [Pediatr Transplant] 2021 Nov; Vol. 25 (7), pp. e14077. Date of Electronic Publication: 2021 Jul 03.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Kidney Transplantation*
Graft Rejection/*prevention & control
Immunosuppression Therapy/*trends
Immunosuppressive Agents/*therapeutic use
Child ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Steroid therapy in children with IgA nephropathy.
Autorzy:
Cambier A; Pediatric Department of Nephrology and Transplantation, Assistance Publique-Hôpitaux de Paris, Hôpital Robert-Debré, Paris, France. .
Boyer O; Pediatric Department of Nephrology and Transplantation, Assistance Publique-Hôpitaux de Paris, Hôpital Necker, Paris, France.
Deschenes G; Pediatric Department of Nephrology and Transplantation, Assistance Publique-Hôpitaux de Paris, Hôpital Robert-Debré, Paris, France.
Gleeson J; Université Paris Diderot, Faculté de Médecine, Site Xavier Bichat, INSERM U1149 & CNRS ERL8252, Centre de Recherche sur l'Inflammation, Paris, France.
Couderc A; Pediatric Department of Nephrology and Transplantation, Assistance Publique-Hôpitaux de Paris, Hôpital Robert-Debré, Paris, France.
Hogan J; Pediatric Department of Nephrology and Transplantation, Assistance Publique-Hôpitaux de Paris, Hôpital Robert-Debré, Paris, France.
Robert T; Department of Nephrology, Transplantation and Emergency, Assistance Publique-Hôpitaux de Marseille, Hôpital de la Conception, Marseille, France. .
Pokaż więcej
Źródło:
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2020 Mar; Vol. 35 (3), pp. 359-366. Date of Electronic Publication: 2019 Feb 18.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Glomerulonephritis, IGA/*drug therapy
Glucocorticoids/*therapeutic use
Immunosuppression Therapy/*standards
Immunosuppressive Agents/*therapeutic use
Kidney Failure, Chronic/*prevention & control
Adolescent ; Age Factors ; Biopsy ; Child ; Consensus ; Glomerular Filtration Rate/immunology ; Glomerulonephritis, IGA/complications ; Glomerulonephritis, IGA/immunology ; Glomerulonephritis, IGA/pathology ; Humans ; Immunosuppression Therapy/adverse effects ; Immunosuppression Therapy/methods ; Kidney Failure, Chronic/epidemiology ; Kidney Failure, Chronic/immunology ; Kidney Failure, Chronic/pathology ; Kidney Glomerulus/immunology ; Kidney Glomerulus/pathology ; Kidney Glomerulus/physiopathology ; Practice Guidelines as Topic ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Early combined immunosuppression may be effective and safe in older patients with Crohn's disease: post hoc analysis of REACT.
Autorzy:
Singh S; Division of Gastroenterology, University of California San Diego, La Jolla, California.; Division of Biomedical Informatics, University of California San Diego, La Jolla, California.
Stitt LW; Robarts Research Institute, London, Ontario, Canada.
Zou G; Robarts Research Institute, London, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.
Khanna R; Robarts Research Institute, London, Ontario, Canada.; Department of Medicine, Division of Gastroenterology, University Hospital, Ontario, Canada.
Dulai PS; Division of Gastroenterology, University of California San Diego, La Jolla, California.
Sandborn WJ; Division of Gastroenterology, University of California San Diego, La Jolla, California.
Feagan BG; Robarts Research Institute, London, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.; Department of Medicine, Division of Gastroenterology, University Hospital, Ontario, Canada.
Jairath V; Robarts Research Institute, London, Ontario, Canada.; Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada.; Department of Medicine, Division of Gastroenterology, University Hospital, Ontario, Canada.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2019 May; Vol. 49 (9), pp. 1188-1194. Date of Electronic Publication: 2019 Mar 19.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunosuppression Therapy*/adverse effects
Immunosuppression Therapy*/methods
Crohn Disease/*drug therapy
Immunosuppressive Agents/*administration & dosage
Immunosuppressive Agents/*adverse effects
Adrenal Cortex Hormones/administration & dosage ; Adrenal Cortex Hormones/adverse effects ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; Antimetabolites/administration & dosage ; Antimetabolites/adverse effects ; Crohn Disease/epidemiology ; Crohn Disease/immunology ; Drug Administration Schedule ; Drug Therapy, Combination/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Remission Induction ; Retrospective Studies ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pharmacological preconditioning with adenosine A 1 receptor agonist induces immunosuppression and improves graft survival in novel allogeneic transplantation models.
Autorzy:
Naamani O; Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev and Soroka University Medical Center, Beer-Sheva, Israel. .; Department of Science, Hemdat Hadarom, College of Education, Netivot, Israel. .
Riff R; Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev and Soroka University Medical Center, Beer-Sheva, Israel.
Chaimovitz C; Department of Nephrology, Faculty of Health Sciences, Ben-Gurion University of the Negev and Soroka University Medical Center, Beer-Sheva, Israel.
Mazar J; Laboratory of Hematology, Faculty of Health Sciences, Ben-Gurion University of the Negev and Soroka University Medical Center, Beer-Sheva, Israel.
Douvdevani A; Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev and Soroka University Medical Center, Beer-Sheva, Israel.; Department of Nephrology, Faculty of Health Sciences, Ben-Gurion University of the Negev and Soroka University Medical Center, Beer-Sheva, Israel.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 Mar 11; Vol. 10 (1), pp. 4464. Date of Electronic Publication: 2020 Mar 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Immunosuppression Therapy*
Transplantation Conditioning*/methods
Adenosine A1 Receptor Agonists/*pharmacology
Graft Survival/*drug effects
Graft Survival/*immunology
Immunosuppressive Agents/*pharmacology
Animals ; Blood Cells/drug effects ; Blood Cells/immunology ; Blood Cells/metabolism ; Cell Proliferation ; Mice ; Models, Animal ; Receptor, Adenosine A1/metabolism ; Skin Transplantation ; Transplantation, Homologous
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study.
Autorzy:
Fang M; Department of Hematology-Oncology, Pediatric Hematology-oncology Center, The Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center For Child Health, Hangzhou, PR China.
Song H; Department of Hematology-Oncology, Pediatric Hematology-oncology Center, The Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center For Child Health, Hangzhou, PR China.
Zhang J; Department of Hematology-Oncology, Pediatric Hematology-oncology Center, The Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center For Child Health, Hangzhou, PR China.
Li S; Department of Hematology-Oncology, Pediatric Hematology-oncology Center, The Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center For Child Health, Hangzhou, PR China.
Shen D; Department of Hematology-Oncology, Pediatric Hematology-oncology Center, The Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center For Child Health, Hangzhou, PR China.
Tang Y; Department of Hematology-Oncology, Pediatric Hematology-oncology Center, The Children's Hospital of Zhejiang University School of Medicine, National Clinical Research Center For Child Health, Hangzhou, PR China.
Pokaż więcej
Źródło:
Pediatric hematology and oncology [Pediatr Hematol Oncol] 2021 Oct; Vol. 38 (7), pp. 633-646. Date of Electronic Publication: 2021 Mar 16.
Typ publikacji:
Journal Article
MeSH Terms:
Anemia, Aplastic*/drug therapy
Benzoates/*therapeutic use
Hydrazines/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Pyrazoles/*therapeutic use
Animals ; Antilymphocyte Serum/therapeutic use ; Benzoates/adverse effects ; Child ; China ; Cyclosporine/therapeutic use ; Humans ; Hydrazines/adverse effects ; Immunosuppression Therapy ; Immunosuppressive Agents/adverse effects ; Pyrazoles/adverse effects ; Retrospective Studies ; Swine ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of cyclosporine in a patient with lupus mesenteric vasculitis refractory to conventional immunosuppressive therapy.
Autorzy:
Yıldırım F; Department of Rheumatology, Istanbul Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.
Yalcin Mutlu M; Department of Rheumatology, Istanbul Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.
Erdogan M; Department of Rheumatology, Istanbul Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.
Yardimci AH; Department of Radiology, Istanbul Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.
Bes C; Department of Rheumatology, Istanbul Basaksehir Cam and Sakura City Hospital, University of Health Sciences, Istanbul, Turkey.
Pokaż więcej
Źródło:
Lupus [Lupus] 2021 Oct; Vol. 30 (11), pp. 1866-1867. Date of Electronic Publication: 2021 Jul 11.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Cyclosporine*/pharmacology
Cyclosporine*/therapeutic use
Immunosuppressive Agents*/pharmacology
Immunosuppressive Agents*/therapeutic use
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Peritoneal Diseases*/diagnostic imaging
Peritoneal Diseases*/drug therapy
Vasculitis*/diagnosis
Vasculitis*/diagnostic imaging
Vasculitis*/drug therapy
Mesentery/*blood supply
Adult ; Female ; Humans ; Immunosuppression Therapy/adverse effects ; Mesentery/diagnostic imaging ; Splanchnic Circulation/drug effects
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Relationship between plasma rabbit anti-thymocyte globulin concentration and immunosuppressive therapy response in patients with severe aplastic anemia.
Autorzy:
Narita A; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Muramatsu H; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Ichikawa D; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hamada M; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nishikawa E; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Suzuki K; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kawashima N; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Okuno Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nishio N; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Hama A; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Department of Hematology and Oncology, Children's Medical Center, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
Yamazaki H; Division of Transfusion Medicine, Kanazawa University Hospital, Kanazawa, Japan.
Nakao S; Department of Hematology and Respirology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Kojima S; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takahashi Y; Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2021 Aug; Vol. 107 (2), pp. 255-264. Date of Electronic Publication: 2021 Jun 03.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Anemia, Aplastic/*diagnosis
Anemia, Aplastic/*drug therapy
Antilymphocyte Serum/*blood
Immunosuppressive Agents/*therapeutic use
Adolescent ; Adult ; Aged ; Anemia, Aplastic/etiology ; Anemia, Aplastic/mortality ; Biomarkers ; Child ; Child, Preschool ; Comorbidity ; Disease Management ; Female ; Humans ; Immune Reconstitution ; Immunophenotyping ; Immunosuppression Therapy ; Immunosuppressive Agents/pharmacology ; Infant ; Lymphocyte Count ; Male ; Middle Aged ; Prognosis ; ROC Curve ; Severity of Illness Index ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Kras-driven intratumoral heterogeneity triggers infiltration of M2 polarized macrophages via the circHIPK3/PTK2 immunosuppressive circuit.
Autorzy:
Katopodi T; Department of Medicine, Laboratory of Medical Biology and Genetics, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.
Petanidis S; Department of Medicine, Laboratory of Medical Biology and Genetics, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece. .; Department of Pulmonology, I.M. Sechenov First Moscow State Medical University, Moscow, 119992, Russian Federation. .
Domvri K; Pulmonary Department-Oncology Unit, 'G. Papanikolaou' General Hospital, Aristotle University of Thessaloniki, 57010, Thessaloniki, Greece.
Zarogoulidis P; Third Department of Surgery, 'AHEPA' University Hospital, Aristotle University of Thessaloniki, 55236, Thessaloniki, Greece.
Anestakis D; Department of Anatomy, Medical School, University of Cyprus, 1678, Nicosia, Cyprus.
Charalampidis C; Department of Anatomy, Medical School, University of Cyprus, 1678, Nicosia, Cyprus.
Tsavlis D; Department of Medicine, Laboratory of Experimental Physiology, Aristotle University of Thessaloniki, 54124, Thessaloniki, Greece.
Bai C; Department of Respiratory and Critical Care Medicine, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China.
Huang H; Department of Respiratory and Critical Care Medicine, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China.
Freitag L; Department of Pulmonology, University Hospital Zurich, 8091, Zurich, Switzerland.
Hohenforst-Schmidt W; Medical Clinic I, 'Fuerth' Hospital, University of Erlangen, 91054, Fuerth, Germany.
Matthaios D; Oncology Department, General Hospital of Rodos, 85133, Rhodes, Greece.
Porpodis K; Pulmonary Department-Oncology Unit, 'G. Papanikolaou' General Hospital, Aristotle University of Thessaloniki, 57010, Thessaloniki, Greece.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jul 29; Vol. 11 (1), pp. 15455. Date of Electronic Publication: 2021 Jul 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Carcinoma, Non-Small-Cell Lung/*metabolism
Immunosuppressive Agents/*therapeutic use
Lung Neoplasms/*metabolism
Macrophages/*metabolism
A549 Cells ; Animals ; Apoptosis ; CD4-Positive T-Lymphocytes/cytology ; Disease Progression ; Disease-Free Survival ; Humans ; Immunosuppression Therapy ; Macrophage Activation ; Male ; Mice ; Mice, Inbred C57BL ; Mutation ; Neoplasm Metastasis ; RNA, Circular/metabolism ; RNA, Small Interfering/metabolism ; Signal Transduction ; Tumor Microenvironment/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 1933

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies